Adults taking metformin for type 2 diabetes are less likely to be tested for vitamin B12 status.
Although long-term metformin therapy is associated with lower serum vitamin B12 concentration, high-risk users are often not monitored for vitamin B12 deficiency.
In astudypublished in theJournal of the American Geriatrics Society, investigators sought to examine the association between long-term metformin therapy and serum vitamin B12 monitoring.
The retrospective cohort study included 3687 veterans 50 years or older with type 2 diabetes and long-term metformin therapy, and 13,258 veterans without diabetes and no prescription for metformin, recruited from a single Veterans Affairs Medical Center (VAMC).
Diabetes status was determined from outpatient visits, and long-term metformin therapy was defined as a prescription ≥500 mg/d for at least 6 consecutive months. The investigators estimated the proportion of participants who received a serum B12 test and used a multivariable logistic regression—–which was stratified by age­­––to evaluate the association between metformin use and serum B12 testing.
The results of the study showed that, of the patients with diabetes who were receiving metformin, only 37% were tested for vitamin B12 status after long-termmetforminprescription.
In the metformin-exposed group, the mean B12 concentration was significantly lower compared with the group without diabetes.
Approximately 7% of study participants who received metformin had a vitamin B12 deficiency compared with 3% of patients without diabetes or metformin use.
Dependent on age, metformin users were 2 to 3 times more likely not to receive vitamin B12 testing compared with those without metformin exposure, according to the study. The findings were the same after adjusting for sex, race/ethnicity, body mass index, and number of years treated at the VAMC.
“Long-term metformin therapy is significantly associated with lower serum vitamin B12 concentrations, yet those at risk are often not monitored for B12 deficiency,” the authors wrote. “Because metformin is first-line therapy for type 2 diabetes, clinical decision support should be considered to promote serum B12 monitoring among long-term metformin users for timely identification of the potential need for B12 replacement.”
Novel Region in Human Genome in Those With African Ancestry Limits HIV Replication
August 8th 2023After identifying the CHD1L gene, investigators explored the biological mechanism for the genetic association in those of African descent, determining the gene limits HIV replication in a subset of white blood cells.